![]()
|
Report Date : |
30.07.2007 |
IDENTIFICATION DETAILS
|
Name : |
SEJEONG KOREA CO., LTD. |
|
|
|
|
Registered Office : |
2nd Fl., 466-8, Gunja-dong, Gwangjin-gu, |
|
|
|
|
Country : |
|
|
|
|
|
Financials (as on) : |
31.12.2004 |
|
|
|
|
Date of Incorporation : |
09/29/1990 |
|
|
|
|
Legal Form : |
Company Limited by shares |
|
|
|
|
Line of Business : |
Wholesale of Medical, Professional and Scientific Instruments and
Equipment. |
RATING & COMMENTS
|
MIRA’s Rating : |
Ba |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
Status : |
Satisfactory |
|
|
|
|
Payment Behaviour : |
Usually correct |
|
|
|
|
Litigation : |
Clear |
|
Company
Name |
SEJEONG KOREA CO., LTD. |
|
Registered Address |
466-8, Gunja-dong, Gwangjin-gu, |
|
Building |
2nd Fl. |
|
Zip Code |
143-838 |
|
Tel |
+82-2-461-9254 |
|
Fax |
+82-2-469-4258 |
|
E-mail |
webmaster@healthfirst.co.k; sjkmedical@daum.net |
|
Website |
|
|
Trading Address |
2nd Fl., 466-8, Gunja-dong, Gwangjin-gu, |
|
Tel |
+82-2-461-9254 |
|
Fax |
+82-2-469-4258 |
|
Industry |
Wholesale of Medical, Professional and Scientific Instruments and
Equipment |
|
Main Business |
Sphygmomanometry, Wheel Chair, Gauze, Injector |
|
Sub
Business |
Electronic Commerce Via Internet |
|
Established (mm/dd/yyyy) |
09/29/1990 |
Detailed Products
|
Activity |
Detailed Products (UNSPSC) |
|
Sell |
Medical equipment and accessories and
supplies(42000000) |
|
Sell |
Baby and toddler furniture and
accessories(56101800) |
|
Sell |
Rehabilitation exercise devices and
equipment(42251600) |
|
Sell |
Patient care and treatment products and
supplies(42140000) |
|
Sell |
Physical and occupational therapy and
rehabilitation products(42250000) |
CEO’s
|
Name |
Kang Dae-Hoon |
|
Address |
89, Bangi-dong, Songpa-gu, |
|
Date of Birth |
09/25/1950 |
|
Title |
President & CEO |
|
Sex |
Male |
|
Nationality |
Korean |
Profiles
|
Capital |
400,000,000 KRW |
|
Employees |
11 |
|
Formation |
Co., Ltd by shares |
|
Bank Details |
S.C. First Bank of Nonghyup Bank |
|
Corporate Registered No. |
110111-1591711 |
|
Business Registered No. |
207-81-52791 |
|
Permit & Licenses |
Int’l Trade No.: 11635350 |
|
Shareholder Position |
Kang Dae-Hoon - 40.0% Park Ye-Chun -40.0% Jung-Duck-Hoon-10.0% |
|
Company History |
10/01/1990 Established as Sejung Co. 09/29/1998 Incorporated as Sejung Co.,
Ltd. 09/29/1998 Changed company name to the
present name 12/27/2001 Increased capital to
400,000,000 KRW from 200,000,000 KRW |
|
|
|
Management
|
Job Description |
Title |
Name |
Sex |
Nationality |
Inauguration Day |
|
President & CEO |
Mr. |
Kang Dae-Hoon |
Male |
Korean |
09/29/1998 |
|
Director |
M/S. |
Park Ye-Chun |
Female |
Korean |
09/29/1998 |
|
Director |
Mr. |
Jung-Duck-Hoon |
Male |
Korean |
09/29/1998 |
|
Auditor |
Mr. |
Park Keun-Eon |
Male |
Korean |
07/19/2000 |
Financials
|
Year |
Sales |
Assets |
Net income |
|
2004 |
4,175,000,000 |
2,110,000,000 |
36,000,000 |
|
2003 |
3,679,000,000 |
1,704,000,000 |
87,000,000 |
|
2002 |
3,189,000,000 |
1,462,000,000 |
73,000,000 |
Financial Description
|
Authorized Capital |
1,000,000,000 |
|
Paid-Up Capital |
400,000,000 |
|
Total Issues Shares |
40,000 |
|
Balance Sheet |
|||
|
Unit : Million Korean Won |
As of 12/31/2004 |
As of 12/31/2003 |
As of 12/31/2002 |
|
Total Assets |
2,110 |
1,704 |
1,462 |
|
Current Assets |
2,070 |
1,640 |
1,392 |
|
-Quick Assets |
1,902 |
1,613 |
1,382 |
|
-Inventories |
168 |
27 |
10 |
|
Fixed Assets |
40 |
64 |
70 |
|
-Investment |
31 |
43 |
43 |
|
-Tangibles |
9 |
21 |
26 |
|
-Intangibles |
- |
- |
1 |
|
Total Liabilities |
1,441 |
1,071 |
908 |
|
Current Liabilities |
1,408 |
1,062 |
886 |
|
Fixed Liabilities |
33 |
9 |
22 |
|
Capital Stock |
400 |
400 |
400 |
|
Capital Surplus |
- |
- |
- |
|
Profit Surplus |
269 |
233 |
154 |
|
Capital Adjustment |
- |
- |
- |
|
Total Equity |
669 |
633 |
554 |
|
Liab. & Shareholder’s Equity |
2,110 |
1,704 |
1,462 |
|
Income Statement |
|||
|
Unit : Million Korean Won |
As of 12/31/2004 |
As of 12/31/2003 |
As of 12/31/2002 |
|
Sales |
4,175 |
3,679 |
3,189 |
|
Cost of Sold Goods |
3,548 |
3,092 |
2,649 |
|
Gross Profit |
627 |
587 |
540 |
|
Selling & Admin. Expenses |
543 |
477 |
444 |
|
Operating Income |
84 |
110 |
97 |
|
Non-Operating Income |
63 |
38 |
31 |
|
Non-Operating expenses |
91 |
43 |
42 |
|
Ordinary Income |
56 |
105 |
86 |
|
Special Income |
- |
- |
- |
|
Income Before Taxes |
56 |
105 |
86 |
|
Income Taxes Expenses |
20 |
18 |
13 |
|
Net Income |
36 |
87 |
73 |
Products,
Technologies, Services
Description
|
Main Products & Services |
The subject distributes the medical
supplies and equipments to the major hospitals. |
Sales by Region (Activity
& Markets)
Not Available.
Court Action
Not Available.
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Unfavourable & favourable factors carry similar weight in credit
consideration. Capability to overcome financial difficulties seems
comparatively below average/normal. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with full
security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
NR |
In view of the lack of information, we have no basis upon which to
recommend credit dealings |
No Rating |
|
This score serves as a reference to assess SC’s credit risk
and to set the amount of credit to be extended. It is calculated from a
composite of weighted scores obtained from each of the major sections of this
report. The assessed factors and their relative weights (as indicated through
%) are as follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)